[1]GazzettaChimicaItaliana,1958,vol.88,p.1147,1153,1159
[1]Patent:WO2014/37900,2014,A1,.Locationinpatent:Paragraph27;28
[2]GazzettaChimicaItaliana,1958,vol.88,p.1147,1153,1159
[3]JournalofMedicinalChemistry,1990,vol.33,#11,p.2944-2946
[1]Patent:WO2014/37900,2014,A1,
[1]Patent:WO2014/37900,2014,A1,
[1]Patent:WO2014/37900,2014,A1,
[1]GazzettaChimicaItaliana,1958,vol.88,p.1147,1153,1159
[2]Patent:CN109160895,2019,A.Locationinpatent:Paragraph0046-0048;0049-0051;0052-0054
[1]Patent:WO2014/37900,2014,A1.Locationinpatent:Paragraph27;28
[2]Patent:WO2019/46318,2019,A1.Locationinpatent:Paragraph00219;00220
[3]GazzettaChimicaItaliana,1958,vol.88,p.1147,1153,1159
[4]JournalofMedicinalChemistry,1990,vol.33,p.2944-2946
[5]Patent:CN109160895,2019,A.Locationinpatent:Paragraph0038-0039;0041-0042;0043-0045
[1]JournalofMedicinalChemistry,1999,vol.42,p.2610-2620
[1]EuropeanJournalofMedicinalChemistry,2003,vol.38,p.855-865
[1]EuropeanJournalofMedicinalChemistry,2003,vol.38,p.855-865
Title: 3-(2-carboxyethyl)-4,6-dichloro-1H-indole-2-carboxylic acid: an allosteric inhibitor of fructose-1,6-bisphosphatase at the AMP site.
Journal: Bioorganic & medicinal chemistry letters 20030616
Title: Hydantoin-substituted 4,6-dichloroindole-2-carboxylic acids as ligands with high affinity for the glycine binding site of the NMDA receptor.
Journal: Journal of medicinal chemistry 20030102